| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $65.3M | -3.4% |
| R&D Expense | $106.7M | -18.8% |
| SG&A Expense | $43.9M | -24.1% |
| Operating Income | -$85.3M | +29.9% |
| Pre-tax Income | -$83.5M | +29.1% |
| Income Tax | -$1.7M | +4.8% |
| Net Income | -$81.9M | +29.4% |
| EPS (Basic) | -$3.84 | +29.9% |
| EPS (Diluted) | -$3.84 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.3M | -13.3% |
| Accounts Receivable | $6.9M | +3.6% |
| Current Assets | $204.3M | -31.9% |
| Total Assets | $280.7M | -25.5% |
| Current Liabilities | $48.6M | -15.6% |
| Total Liabilities | $216.0M | -12.8% |
| Stockholders' Equity | $64.7M | -49.8% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.3M | +75.5% |
| Capital Expenditures | $12.9M | -28.1% |
| Investing Cash Flow | $40.3M | -30.7% |
| Financing Cash Flow | -$26.6M | +3.6% |
| Free Cash Flow | -$32.2M | +66.7% |
| +29.9% |